Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

European markets are heading for a mixed open Tuesday as investors digest the latest tariffs from U.S. President Donald Trump ...

British fibre broadband company CityFibre reported its first full year of profit in 2024 as connected customers on its network passed 500,000, a total that is set to jump this year when major provider ...

Novartis said this morning that its pipeline ... said the company at a 'meet management' event running in London today. The raised forecast reflects increases in the sales projections for a ...

British stars led the charge as the Philadelphia Eagles dominated the Kansas City Chiefs during this year’s Super Bowl.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase is Your Competitive Edge Tod ...

This expanded access enables Novartis to deploy Schrodinger’s full ... will participate in a fireside chat at the Jefferies London Healthcare Conference. NEW YORK, October 31, 2024--Schrödinger ...

Novartis’ new CEO Vas Narasimhan has said ... Next-day delivery is guaranteed, and in central London patients can have their medicines with them in as little as two hours. Owlstone Medical ...

Trump says he will announce 25% steel and aluminum tariffs Monday WASHINGTON (AP) — President Donald Trump was supposed to announce Monday the United States will impose 25% tariffs on ...

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...